
Dr. Hongbing Yu, a research associate in the Jacobson and B. Vallance Research Teams, is working on basic science that could help explain why some kids get intestinal infections and others do not. His work could also lead to the development of novel treatments for inflammatory bowel disease.

The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada through its COVID-19 Immunity Task Force (CITF).

Welcome to this month’s Research Roundup, a recurring overview of recent studies published by researchers at BC Children’s Hospital Research Institute (BCCHR) and the University of British Columbia, and their collaborators.